시장보고서

상품코드

1437515

세계 모르핀 의약품 시장 : 제형별, 용도별, 유통 경로별, 최종 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Morphine Drugs Market, By Dosage Form, By Application, By Distribution Channel, By End Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 02월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 287 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

모르핀 의약품 시장 규모는 2023년에 228억 7,000만 달러로 평가되었고 2024년부터 2032년까지 복합 연간 성장률(CAGR) 4.5%로 확대될 전망입니다

모르핀 의약품 시장 : 시장 역학

만성 질환과 관련된 노년 인구 증가는 시장 성장을 견인

예측 기간 동안 노인 인구 증가와 만성 질환의 유병률 증가로 모르핀과 같은 다양한 오피오이드 의약품에 대한 수요가 증가할 것으로 예측됩니다. 만성 통증과 골관절염 질환은 노인 인구에서 많이 발견됩니다. 2021년 5월 MDPI는 만성 통증이 노인 인구의 50% 이상에 영향을 미치는 심각한 문제임을 보여주는 보고서를 발표했습니다. 또한 관절염의 유병률 상승으로 진통제 수요가 증가할 것으로 예측됩니다. 캐나다 관절염 협회는 65세 이상의 50%가 관절염으로 고통받고 있다고 추정합니다. 이런 식으로 예측 기간 동안 만성 통증을 경험하는 사람들의 수가 세계적으로 증가하고 모르핀 시장을 홍보할 것으로 예상됩니다.

모르핀 의약품 시장 : 주요 인사이트력

리서치 애널리스트의 분석에 따르면 시장은 예측 기간 중(2024-2032년) 복합 연간 성장률(CAGR) 약 4.5%로 연간 성장할 것으로 예측되고 있습니다.

제형 세분화는 주사제가 2023년에 가장 큰 시장 점유율을 나타낼 것으로 예측됩니다.

용도별로는 통증 관리가 2023년의 주요 유형이었습니다.

지역별로는 북미가 2023년 매출을 이끌고 있습니다.

모르핀 의약품 시장 : 세분화 분석 :

세계 모르핀 의약품 시장은 제형, 용도, 유통 채널, 최종 용도, 지역에 따라 세분화됩니다.

시장은 복용 형태에 따라 세 가지 범주로 나뉩니다. 경구, 주사제 등. 주사제가 시장을 독점하고 있습니다. 이 주사의 목적은 중등도에서 심한 통증을 완화하는 것입니다. 또한 수술 전과 수술 중 마취제로도 사용됩니다. 이 시장 진출기업에는 Duramorph, Infumorph, Astramorph PF 등이 있습니다.

시장은 용도에 따라 두 가지 범주로 나뉩니다: 설사, 통증 관리, 감기, 기침 등. 통증 관리 분야는 시장을 독점하고 있으며, 통증 완화제로서 모르핀이 널리 사용되고 있기 때문에 예측 기간 동안에도 그 우위성을 유지할 것으로 보입니다. 모르핀은 사고로 인한 심각한 외상, 진통, 암성 통증, 수술 통증 등 다양한 질병으로 인한 통증 치료 및 완화에 사용됩니다.

모르핀 의약품 시장 : 지리적 인사이트

지리적으로, 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카 각 지역으로 퍼져 있습니다. 이 지역은 비즈니스를 제공하는 국가에 의해 더 나뉩니다. 예측 기간 동안 북미는 시장을 독점할 것으로 예상됩니다. 이 시장은 기존 기업의 존재에 의해 더욱 견조하게 확대될 것으로 예상됩니다. 예측 기간 동안 근골격계 장애의 유병률 증가와 제약 업계의 왕성한 수요도 지역 확대를 지원할 것으로 예측됩니다. 사법성,마약 단속국이 2020년 4월에 발표한 팩트 시트에 의하면, 아편 유래의 모르핀은 미국내의 의약품에 직접 이용되고 있습니다. 그 결과, 이 지역 시장 수요는 제약 산업에서 모르핀을 사용함으로써 예측 기간 동안 견인될 수 있습니다.

제1장 모르핀 의약품 시장 개요

조사 범위
시장 추정 연도

제2장 주요 요약

시장 분석
경쟁 인사이트

제3장 모르핀 의약품의 주요 시장 동향

시장 성장 촉진요인
시장 성장 억제요인
시장 기회
향후 시장 동향

제4장 모르핀 의약품 산업 조사

PEST 분석
Porter's Five Forces 분석
성장 전망 맵핑
규제 틀의 분석

제5장 모르핀약 시장 : COVID-19증의 영향 분석

신형 코로나바이러스 감염증 이전의 영향 분석
신형 코로나바이러스 감염증 후의 영향 분석

제6장 모르핀 의약품 시장 상황

모르핀 의약품 시장 점유율 분석(2023년)
주요 제조업체별 분석 데이터
- 기존 기업의 분석
- 신흥기업의 분석

제7장 모르핀 의약품 시장 :제형별

개요
- 제형별 부문 점유율 분석
- 경구
- 주사
- 기타

제8장 모르핀 의약품 시장 : 용도별

개요
- 용도별 부문 점유율 분석
- 설사 억제제
- 통증 관리
- 감기와 기침
- 기타

제9장 모르핀 의약품 시장 : 유통 채널별

개요
- 판매 채널별 부문 점유율 분석
- 병원 약국
- 소매 약국
- 온라인 약국
- 기타

제10장 모르핀 의약품 시장 : 최종 용도별

개요
- 최종 용도별 부문 점유율 분석
- 외래수술센터(ASC)
- 병원 및 클리닉
- 기타

제11장 모르핀 의약품 시장 :지역별

소개
북미
- 개요
- 북미 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석 - 모르핀 의약품 업계

경쟁 대시보드
기업 프로파일
- Pfizer Inc.
- Mallinckrodt Pharmaceuticals
- AbbVie Inc.
- Delpharm(Sandoz Canada Inc.)
- Dr. Reddy's Laboratories Ltd(Mayne Pharma Group Limited)
- Daiichi Sankyo Company Limited
- Verve Health Care Ltd
- Hikma Pharmaceuticals USA Inc.
- Sun Pharmaceutical Industries Ltd
- Viatris Inc.
- Alcaliber SA
- Sanofi

제13장 애널리스트의 전방위 전망

BJH 24.03.08

REPORT HIGHLIGHT

Morphine Drugs Market size was valued at USD 22,870 Million in 2023, expanding at a CAGR of 4.5% from 2024 to 2032.

When other medications are ineffective or intolerable for the patient, morphine is used to treat moderate to severe pain. An opioid drug called morphine is used to treat pain, either chronic or acute, and it typically works quite well. As an opiate (narcotic) analgesic, morphine is a member of this class of drugs. Through its binding to the mu-opioid receptors in the central nervous system (CNS) and peripheral nervous system (PNS), morphine alters the way the brain and nervous system react to pain.

Morphine Drugs Market- Market Dynamics

Rising geriatric population along with chronic illness drives the market growth

Over the projection period, the demand for different opioid medications like morphine is predicted to rise due to the growing elderly population and the rising prevalence of chronic illnesses. Chronic pain and osteoarthritis diseases are more common in the elderly population. In May 2021, the MDPI published a report indicating that chronic pain was a significant problem impacting over 50% of the elderly population. In addition, it is predicted that the rising prevalence of arthritis would increase demand for painkillers. The Arthritis Society Canada estimates that 50% of those over 65 suffer from arthritis. Thus, during the course of the forecast period, the growing number of people experiencing chronic pain worldwide is anticipated to propel the morphine market.

Morphine Drugs Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.5% over the forecast period (2024-2032)

Based on dosage form segmentation, injection was predicted to show maximum market share in the year 2023

Based on application segmentation, pain management was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Morphine Drugs Market- Segmentation Analysis:

The Global Morphine Drugs Market is segmented based on Dosage Form, Application, Distribution Channel, End Use, and Region.

The market is divided into three categories based on dosage form: Oral, Injection and Others. Injection sector dominates the market. The purpose of these injections is to relieve moderate to severe pain. It can also be used with an anesthetic before to or during surgery. Among the companies in this market are Duramorph, Infumorph, and Astramorph PF.

The market is divided into two categories based on application: Diarrhea Suppressant, Pain Management, Cold & Cough Suppressant and Others. The pain management sector dominates the market and is likely to maintain its dominance during the forecast period due to the widespread usage of morphine as a pain reliever. It can be used to treat or reduce pain from a variety of illnesses, including significant trauma from accidents, labor pain, cancer pain, and surgical pain.

Morphine Drugs Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period. The market is expected to expand more robustly in the presence of established players. Over the projection period, the growing prevalence of musculoskeletal disorders and the strong demand in the pharmaceutical industry are also anticipated to support the regional expansion. As to the April 2020 factsheet released by the Department of Justice and Drug Enforcement Administration, morphine derived from opium is utilized directly in medicinal goods within the United States. Consequently, the region's market demand may be driven over the projection period by the usage of morphine in the pharmaceutical industry.

Morphine Drugs Market- Competitive Landscape:

The market players operating in the Morphine Drugs market are Pfizer Inc., Mallinckrodt Pharmaceuticals, AbbVie Inc., Delpharm (Sandoz Canada Inc.), Dr. Reddy's Laboratories Ltd (Mayne Pharma Group Limited), Daiichi Sankyo Company Limited, Verve Health Care Ltd, Hikma Pharmaceuticals USA Inc., Sun Pharmaceutical Industries Ltd, Viatris Inc., Alcaliber S.A and Sanofi among others. These players adopted various strategies to hold a maximum market share such as product launches, acquisitions, expansion and others.

Recent Developments:

In July 2022, one lot of thirty milligram and one lot of sixty milligram extended-release morphine sulfate tablets (10 bottles each) were voluntarily recalled by Bryant Ranch Prepack Inc. from consumer distribution.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MORPHINE DRUGS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Pfizer Inc.

Mallinckrodt Pharmaceuticals

AbbVie Inc.

Delpharm (Sandoz Canada Inc.)

Dr. Reddy's Laboratories Ltd (Mayne Pharma Group Limited)

Daiichi Sankyo Company Limited

Verve Health Care Ltd

Hikma Pharmaceuticals USA Inc.

Sun Pharmaceutical Industries Ltd

Viatris Inc.

Alcaliber S.A

Sanofi

GLOBAL MORPHINE DRUGS MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019 - 2032

Oral
Injection
Others

GLOBAL MORPHINE DRUGS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Diarrhea Suppressant
Pain Management
Cold & Cough Suppressant
Others

GLOBAL MORPHINE DRUGS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

GLOBAL MORPHINE DRUGS MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

Ambulatory Surgical Centers
Hospitals & Clinics
Others

GLOBAL MORPHINE DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Morphine Drugs Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Morphine Drugs Market Snippet by Dosage Form
- 2.1.2. Morphine Drugs Market Snippet by Application
- 2.1.3. Morphine Drugs Market Snippet by Distribution Channel
- 2.1.4. Morphine Drugs Market Snippet by End Use
- 2.1.5. Morphine Drugs Market Snippet by Country
- 2.1.6. Morphine Drugs Market Snippet by Region
2.2. Competitive Insights

3. Morphine Drugs Key Market Trends

3.1. Morphine Drugs Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Morphine Drugs Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Morphine Drugs Market Opportunities
3.4. Morphine Drugs Market Future Trends

4. Morphine Drugs Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Morphine Drugs Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Morphine Drugs Market Landscape

6.1. Morphine Drugs Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Morphine Drugs Market - By Dosage Form

7.1. Overview
- 7.1.1. Segment Share Analysis, By Dosage Form, 2023 & 2032 (%)
- 7.1.2. Oral
- 7.1.3. Injection
- 7.1.4. Others

8. Morphine Drugs Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2. Diarrhea Suppressant
- 8.1.3. Pain Management
- 8.1.4. Cold & Cough Suppressant
- 8.1.5. Others

9. Morphine Drugs Market - By Distribution Channel

9.1. Overview
- 9.1.1. Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
- 9.1.2. Hospital Pharmacies
- 9.1.3. Retail Pharmacies
- 9.1.4. Online Pharmacies
- 9.1.5. Others

10. Morphine Drugs Market - By End Use

10.1. Overview
- 10.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
- 10.1.2. Ambulatory Surgical Centers
- 10.1.3. Hospitals & Clinics
- 10.1.4. Others

11. Morphine Drugs Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Morphine Drugs Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Morphine Drugs Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.9. Italy
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.9.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.3.9.6. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.10. United Kingdom
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. United Kingdom Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.10.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.3.10.6. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.11. France
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.11.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.3.11.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.12. Russia
  - 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.2. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.13. Netherlands
  - 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2. Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.13.4. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.3.13.5. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.15. Poland
  - 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.16. Rest of Europe
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Morphine Drugs Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.8. India
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.8.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.4.8.6. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.9. China
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.9.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.4.9.6. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.13. Thailand
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.14. Indonesia
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Morphine Drugs Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Morphine Drugs Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Morphine Drugs Industry

12.1. Competitive Dashboard
12.2. Company Profiles
- 12.2.1. Pfizer Inc.
- 12.2.2. Mallinckrodt Pharmaceuticals
- 12.2.3. AbbVie Inc.
- 12.2.4. Delpharm (Sandoz Canada Inc.)
- 12.2.5. Dr. Reddy's Laboratories Ltd (Mayne Pharma Group Limited)
- 12.2.6. Daiichi Sankyo Company Limited
- 12.2.7. Verve Health Care Ltd
- 12.2.8. Hikma Pharmaceuticals USA Inc.
- 12.2.9. Sun Pharmaceutical Industries Ltd
- 12.2.10. Viatris Inc.
- 12.2.11. Alcaliber S.A
- 12.2.12. Sanofi

13. 360 Degree Analyst View

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us